000999 华润三九
已收盘 06-18 15:00:00
资讯
新帖
简况
华润三九:高度重视市值管理工作
证券之星 · 06-16
华润三九:高度重视市值管理工作
华润三九:截至6月10日,公司股东共104,376户
证券之星 · 06-15
华润三九:截至6月10日,公司股东共104,376户
华润三九:理洫王于2021年完成“999理洫王”的品牌变更
证券之星 · 06-15
华润三九:理洫王于2021年完成“999理洫王”的品牌变更
华润三九:已进入200家各级医疗机构
证券之星 · 06-15
华润三九:已进入200家各级医疗机构
华润三九:公司CHC健康消费品业务围绕“大品种-大品牌-大品类”的建设思路进行品牌打造和产品线丰富
证券之星 · 06-15
华润三九:公司CHC健康消费品业务围绕“大品种-大品牌-大品类”的建设思路进行品牌打造和产品线丰富
华润三九:理洫王于2021年完成“999理洫王”的品牌变更
证券之星 · 06-15
华润三九:理洫王于2021年完成“999理洫王”的品牌变更
华润三九宣布子公司拟注册发行不超过100亿元银行间市场债务融资工具
美股速递 · 06-08
华润三九宣布子公司拟注册发行不超过100亿元银行间市场债务融资工具
华润三九新提交“未公开”、“易干复”等4件商标注册申请
证券之星 · 06-06
华润三九新提交“未公开”、“易干复”等4件商标注册申请
华润三九新注册《华润三九公辅物联群控系统V1.0》项目的软件著作权
证券之星 · 06-06
华润三九新注册《华润三九公辅物联群控系统V1.0》项目的软件著作权
华润三九新注册《华润三九中药材GAP管理追溯系统V2.0》项目的软件著作权
证券之星 · 05-28
华润三九新注册《华润三九中药材GAP管理追溯系统V2.0》项目的软件著作权
【机构调研记录】华富基金调研华润三九
证券之星 · 05-22
【机构调研记录】华富基金调研华润三九
【私募调研记录】翼品资产调研华润三九
证券之星 · 05-22
【私募调研记录】翼品资产调研华润三九
华润三九:高度重视市值管理工作
证券之星 · 05-21
华润三九:高度重视市值管理工作
华润三九(000999)披露2025年度权益分派实施公告,5月21日股价下跌0.16%
证券之星 · 05-21
华润三九(000999)披露2025年度权益分派实施公告,5月21日股价下跌0.16%
股市必读:华润三九(000999)股东户数10.01万户,较上期增加12.2%
证券之星 · 05-21
股市必读:华润三九(000999)股东户数10.01万户,较上期增加12.2%
华润三九:截至4月30日,公司股东共100,104户
证券之星 · 05-20
华润三九:截至4月30日,公司股东共100,104户
华润三九:目前正在夯实业务基础
证券之星 · 05-20
华润三九:目前正在夯实业务基础
华润三九:HiCM-188为全球首个在中、美两国同时获批临床默示许可的基于诱导多能干细胞的心衰再生治疗创新药
证券之星 · 05-20
华润三九:HiCM-188为全球首个在中、美两国同时获批临床默示许可的基于诱导多能干细胞的心衰再生治疗创新药
京东健康(06618)与华润三九发起“基层健康守护计划” 共同推动优质中医药资源下沉
智通财经网 · 04-28
京东健康(06618)与华润三九发起“基层健康守护计划” 共同推动优质中医药资源下沉
华润三九(000999)4月10日股东户数8.92万户,较上期增加6.36%
证券之星 · 04-25
华润三九(000999)4月10日股东户数8.92万户,较上期增加6.36%
暂无数据
公司概况
公司名称:
华润三九医药股份有限公司
所属行业:
医药制造业
上市日期:
2000-03-09
主营业务:
华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是自我诊疗(CHC)、处方药、包装印刷、药品、器械批发与零售。公司先后建有国家中成药工程技术研究中心、国家企业技术中心、经典名方现代中药创制全国重点实验室等国家级、省级创新平台,加强关键共性技术攻关,整合行业资源,实现技术与成果孵化,目前公司已获得9项国家科技进步二等奖。
发行价格:
8.45
{"stockData":{"symbol":"000999","market":"SZ","secType":"STK","nameCN":"华润三九","latestPrice":23.48,"timestamp":1781766195000,"preClose":23.79,"halted":0,"volume":6863719,"delay":0,"changeRate":-0.013,"floatShares":1663000000,"shares":1664000000,"eps":1.939,"marketStatus":"已收盘","change":-0.31,"latestTime":"06-18 15:00:00","open":23.72,"high":23.82,"low":23.45,"amount":162000000,"amplitude":0.0156,"askPrice":23.49,"askSize":421,"bidPrice":23.48,"bidSize":79,"shortable":0,"etf":0,"ttmEps":1.939,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782091800000},"marketStatusCode":5,"adr":0,"adjPreClose":23.79,"symbolType":"stock","openAndCloseTimeList":[[1781746200000,1781753400000],[1781758800000,1781766000000]],"highLimit":26.17,"lowLimit":21.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1664217858,"isCdr":false,"pbRate":1.7,"roa":"--","peRate":12.109335,"roe":"4.74%","epsLYR":2.06,"committee":0.044724,"marketValue":39076000000,"turnoverRate":0.0041,"status":1,"floatMarketCap":39040000000},"requestUrl":"/m/hq/s/000999/tweets","defaultTab":"tweets","newsList":[{"id":"2643576997","title":"华润三九:高度重视市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2643576997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643576997?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:48","pubTimestamp":1781614098,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问:股价逆势跌跌不休,请问管理人是否有措施稳定股价?华润三九回复:您好,二级市场股价波动受宏观经济环境、市场情绪、投资者风险偏好等多重因素影响。公司高度重视市值管理工作,围绕公司发展战略,聚焦主业发展,持续提升公司核心竞争力,重视股东回报,持续现金分红,努力推动高质量发展。感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600041782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","000999","BK0028","BK0185","BK0012","BK0196","BK0239","BK0060","BK0183","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643908276","title":"华润三九:截至6月10日,公司股东共104,376户","url":"https://stock-news.laohu8.com/highlight/detail?id=2643908276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643908276?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:30","pubTimestamp":1781512238,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问:现在6月份的最新的股东人数是多少?十大股东有没有变化?华润三九回复:您好,截至6月10日,公司股东共104,376户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500019783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","000999","BK0060","BK0239","BK0185","BK0196","BK0183","BK0010","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643927662","title":"华润三九:理洫王于2021年完成“999理洫王”的品牌变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2643927662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643927662?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:27","pubTimestamp":1781512036,"startTime":"0","endTime":"0","summary":"理洫王于2021年完成“999理洫王”的品牌变更,此变更仅为产品包装的视觉升级,未涉及药品核心属性调整,国药准字、医保编码均保持不变,不影响产品的临床使用、医保报销及集采执行。二是理洫王正实行渠道差异化品牌过渡策略,医疗端已完成“777理洫王”包装切换,零售端仍以“999理洫王”为主,后续将根据策略逐步更新为“777理洫王”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500019681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0010","BK0012","BK0175","BK0028","BK0188","000999","BK0060","BK0183","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643276575","title":"华润三九:已进入200家各级医疗机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2643276575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643276575?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:27","pubTimestamp":1781512036,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘好,请问益气清肺颗粒进入全国医院了吗?进入程度是怎样的?周末去我所在的地级三甲医院医诊,想让医生开一些,医生说医院没有此药。华润三九回复:您好,目前公司999益气清肺颗粒在有序开展上市后学术推广和挂网销售等相关工作,已进入200家各级医疗机构。您或可通过医保服务平台APP,查询医疗机构配备情况,感谢您的关注。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500019682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0183","BK0196","BK0239","BK0012","BK0060","BK0185","BK0175","000999","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643276684","title":"华润三九:公司CHC健康消费品业务围绕“大品种-大品牌-大品类”的建设思路进行品牌打造和产品线丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2643276684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643276684?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:24","pubTimestamp":1781511857,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九06月15日在投资者关系平台上答复投资者关心的问题。作为一家中药企业,华润三九获得了显著的成功,但我认为公司还没搞清楚在卖什么,考虑不清楚这个问题公司的天花板就是明显的。我认为华润三九服务于人体的代谢与循环,这也可以认为是中医理论的现代翻译。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500019459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000999","BK0028","BK0060","BK0196","BK0188","BK0175","BK0010","BK0012","BK0185","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643276613","title":"华润三九:理洫王于2021年完成“999理洫王”的品牌变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2643276613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643276613?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:24","pubTimestamp":1781511857,"startTime":"0","endTime":"0","summary":"理洫王于2021年完成“999理洫王”的品牌变更,此变更仅为产品包装的视觉升级,未涉及药品核心属性调整,国药准字、医保编码均保持不变,不影响产品的临床使用、医保报销及集采执行。二是理洫王正实行渠道差异化品牌过渡策略,医疗端已完成“777理洫王”包装切换,零售端仍以“999理洫王”为主,后续将根据策略逐步更新为“777理洫王”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500019457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0060","BK0028","BK0012","BK0175","000999","BK0183","BK0185","BK0010","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195262614","title":"华润三九宣布子公司拟注册发行不超过100亿元银行间市场债务融资工具","url":"https://stock-news.laohu8.com/highlight/detail?id=1195262614","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195262614?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:06","pubTimestamp":1780913210,"startTime":"0","endTime":"0","summary":"华润三九医药股份有限公司近日披露,其下属子公司计划在银行间市场注册并发行总额不超过人民币100亿元的债务融资工具。此举旨在进一步拓宽融资渠道,优化债务结构,为公司业务发展提供资金支持。具体发行条款将根据市场状况和公司资金需求适时确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0185","BK0060","BK0183","BK0188","BK0012","BK0196","BK0010","BK0239","000999","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123963","title":"华润三九新提交“未公开”、“易干复”等4件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123963","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641123963?lang=zh_cn&edition=full","pubTime":"2026-06-06 07:27","pubTimestamp":1780702036,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日华润三九医药股份有限公司新提交“未公开”、“易干复”等4件商标注册申请。商标申请详情如下:今年以来华润三九医药股份有限公司新申请注册商标9件,截止目前公司共持有注册商标4050件,另有408件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060600003917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0010","BK0188","000999","BK0060","BK0028","BK0185","BK0183","BK0239","BK0012","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641142367","title":"华润三九新注册《华润三九公辅物联群控系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2641142367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641142367?lang=zh_cn&edition=full","pubTime":"2026-06-06 02:25","pubTimestamp":1780683911,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华润三九(000999)新注册了《华润三九公辅物联群控系统V1.0》项目的软件著作权。今年以来华润三九新注册软件著作权3个。结合公司2025年年报财务数据,2025年公司在研发方面投入了12.68亿元,同比增58.16%。通过天眼查大数据分析,华润三九医药股份有限公司共对外投资了50家企业,参与招投标项目9267次;财产线索方面有商标信息3347条,专利信息601条,著作权信息121条;此外企业还拥有行政许可478个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060600000085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","159180","BK0185","BK0060","BK0028","BK0183","BK0188","BK0239","BK0196","BK0175","BK0010","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638213680","title":"华润三九新注册《华润三九中药材GAP管理追溯系统V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638213680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638213680?lang=zh_cn&edition=full","pubTime":"2026-05-28 02:06","pubTimestamp":1779905176,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华润三九(000999)新注册了《华润三九中药材GAP管理追溯系统V2.0》项目的软件著作权。今年以来华润三九新注册软件著作权2个。结合公司2025年年报财务数据,2025年公司在研发方面投入了12.68亿元,同比增58.16%。通过天眼查大数据分析,华润三九医药股份有限公司共对外投资了50家企业,参与招投标项目9142次;财产线索方面有商标信息3347条,专利信息597条,著作权信息121条;此外企业还拥有行政许可451个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800001360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0010","BK0188","159180","BK0012","BK0196","BK0239","BK0183","BK0060","BK0028","000999","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637363906","title":"【机构调研记录】华富基金调研华润三九","url":"https://stock-news.laohu8.com/highlight/detail?id=2637363906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637363906?lang=zh_cn&edition=full","pubTime":"2026-05-22 08:01","pubTimestamp":1779408080,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及5月21日披露的机构调研信息,华富基金近期对1家上市公司进行了调研,相关名单如下:1)华润三九 调研纪要:BGM0504注射液III期临床显示,试验组体重较基线最高降低19.2%,腰围改善16.5cm,血压、血脂、骨密度及糖代谢指标均显著改善。华富基金成立于2004年,截至目前,资产管理规模1296.99亿元,排名54/212;资产管理规模811.96亿元,排名57/212;管理公募基金数184只,排名44/212;旗下公募基金经理21人,排名70/212。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200007543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0185","BK0012","BK0196","BK0060","000999","BK0175","BK0010","BK0028","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637363139","title":"【私募调研记录】翼品资产调研华润三九","url":"https://stock-news.laohu8.com/highlight/detail?id=2637363139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637363139?lang=zh_cn&edition=full","pubTime":"2026-05-22 08:01","pubTimestamp":1779408073,"startTime":"0","endTime":"0","summary":"根据市场公开信息及5月21日披露的机构调研信息,知名私募翼品资产近期对1家上市公司进行了调研,相关名单如下:1)华润三九 调研纪要:BGM0504注射液III期临床显示,试验组体重较基线最高降低19.2%,腰围改善16.5cm,血压、血脂、骨密度及糖代谢指标均显著改善。研发投入由2020年5.81亿元增至2025年17.34亿元,在研项目203项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026052200007535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0183","BK0196","BK0239","BK0012","BK0060","BK0185","BK0175","000999","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637336279","title":"华润三九:高度重视市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2637336279","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637336279?lang=zh_cn&edition=full","pubTime":"2026-05-21 20:51","pubTimestamp":1779367884,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司股价一直跌跌不休,请问有没有大股东增持回购计划?华润三九回复:您好,二级市场股价波动受宏观经济环境、市场情绪、投资者风险偏好等多重因素影响。公司高度重视市值管理工作,围绕公司发展战略,聚焦主业发展,持续提升公司核心竞争力,重视股东回报,持续现金分红,努力推动高质量发展。感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100042343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0175","BK0196","000999","BK0185","BK0183","BK0010","BK0012","BK0028","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382595","title":"华润三九(000999)披露2025年度权益分派实施公告,5月21日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637382595?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:19","pubTimestamp":1779358757,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,华润三九报收于24.65元,较前一交易日下跌0.16%,最新总市值为410.23亿元。该股当日开盘24.7元,最高24.94元,最低24.61元,成交额达1.51亿元,换手率为0.37%。华润三九于近日披露《2025年度权益分派实施公告》。股权登记日为2026年5月28日,除权除息日为2026年5月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","000999","BK0010","BK0060","BK0183","BK0196","BK0185","BK0028","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637822463","title":"股市必读:华润三九(000999)股东户数10.01万户,较上期增加12.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637822463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637822463?lang=zh_cn&edition=full","pubTime":"2026-05-21 02:18","pubTimestamp":1779301091,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,华润三九报收于24.69元,下跌1.0%,换手率0.29%,成交量4.85万手,成交额1.2亿元。来自公司公告汇总:华润三九2025年度权益分派方案确定,每10股派发现金红利5.90元(含税),股权登记日为2026年5月28日。股本股东变化股东户数变动近日华润三九披露,截至2026年4月30日公司股东户数为10.01万户,较4月10日增加1.09万户,增幅为12.2%。户均持股数量由上期的1.87万股减少至1.66万股,户均持股市值为43.08万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100002490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","BK0010","BK0239","BK0196","BK0183","BK0012","BK0175","BK0185","000999","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636581442","title":"华润三九:截至4月30日,公司股东共100,104户","url":"https://stock-news.laohu8.com/highlight/detail?id=2636581442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636581442?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:18","pubTimestamp":1779265095,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2026年4月30日公司的股东总数是多少?谢谢华润三九回复:您好,截至4月30日,公司股东共100,104户。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000029048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0028","BK0012","BK0196","BK0175","BK0188","BK0239","000999","BK0060","BK0183","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636144958","title":"华润三九:目前正在夯实业务基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2636144958","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636144958?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:15","pubTimestamp":1779264921,"startTime":"0","endTime":"0","summary":"证券之星消息,华润三九(000999)05月20日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,根据此前华润三九关于解决同业竞争的公告,昆药集团医药商业板块将并入华润三九体系。请问:1. 目前昆药商业板块的整合交割预计何时完成?2. 本次整合对公司渠道体系的优化进展如何?华润三九回复:华润三九收购昆药集团涉及到的同业竞争主要是商业流通业务,已承诺在5年内解决同业竞争问题,目前正在夯实业务基础。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000028660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0183","BK0060","000999","BK0196","BK0185","BK0239","BK0012","BK0175","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636814129","title":"华润三九:HiCM-188为全球首个在中、美两国同时获批临床默示许可的基于诱导多能干细胞的心衰再生治疗创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2636814129","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636814129?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:12","pubTimestamp":1779264739,"startTime":"0","endTime":"0","summary":"从新闻得知华润三九大举进军CGT,与深圳三院共建CGT联合实验室,打通医企研全链条转化路径,加速细胞与基因治疗产业化。华润三九积极布局细胞与基因治疗领域,已有多个在研管线,天士力已有3项CGT药物现已处于临床I期阶段,公司达成HiCM-188 项目联合研发合作,HiCM-188 为全球首个在中、美两国同时获批临床默示许可的基于诱导多能干细胞的心衰再生治疗创新药,助力公司进一步拓展细胞治疗赛道,更好地满足终末期心衰临床需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000028293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0196","BK1574","06978","BK0185","BK1161","BK0060","BK0028","BK0183","BK0188","BK0239","159992","BK0175","BK0010","000999"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630340945","title":"京东健康(06618)与华润三九发起“基层健康守护计划” 共同推动优质中医药资源下沉","url":"https://stock-news.laohu8.com/highlight/detail?id=2630340945","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630340945?lang=zh_cn&edition=full","pubTime":"2026-04-28 10:17","pubTimestamp":1777342679,"startTime":"0","endTime":"0","summary":"京东健康与华润三九共同发起“基层健康守护计划”。双方将依托各自在数智技术、平台资源与中药供应链领域的优势,推动优质中医药服务向基层下沉,助力解决基层诊疗资源不足、服务能力有限等现实问题。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260428/20260428101535_57821.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260428/20260428101535_57821.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1247","000999","BK1615","BK1591","SGXZ86797644.SGD","BK0239","BK1583","86618","06618","BK0196","LU0456827905.SGD","LU0051755006.USD","BK0060","BK0010","SGXZ62798434.SGD","BK1142","BK1589","BK0188","BK0185","BK0175","BK1515","BK1571","BK0028","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630187036","title":"华润三九(000999)4月10日股东户数8.92万户,较上期增加6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630187036","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630187036?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:08","pubTimestamp":1777108131,"startTime":"0","endTime":"0","summary":"证券之星消息,近日华润三九披露,截至2026年4月10日公司股东户数为8.92万户,较3月31日增加5337.0户,增幅为6.36%。在中药行业个股中,华润三九股东户数高于行业平均水平,截至4月10日,中药行业平均股东户数为5.31万户。从股价来看,2026年3月31日至2026年4月10日,华润三九区间跌幅为0.5%,在此期间股东户数增加5337.0户,增幅为6.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0183","BK0060","000999","BK0196","BK0185","BK0239","BK0012","BK0175","BK0010"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782083371850,"stockEarnings":[{"period":"1week","weight":-0.0494},{"period":"1month","weight":-0.035},{"period":"3month","weight":-0.1875},{"period":"6month","weight":-0.152},{"period":"1year","weight":-0.212},{"period":"ytd","weight":-0.1544}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.0337},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2071},{"period":"ytd","weight":0.0306}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华润三九医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"104376人(较上一季度增加0.13%)","perCapita":"15929股","listingDate":"2000-03-09","address":"广东省深圳市龙华区观湖街道观澜高新园区观清路1号","registeredCapital":"166421万元","survey":" 华润三九医药股份有限公司的主营业务是高质量医药健康产品创新研发和智能制造。公司的主要产品是自我诊疗(CHC)、处方药、包装印刷、药品、器械批发与零售。公司先后建有国家中成药工程技术研究中心、国家企业技术中心、经典名方现代中药创制全国重点实验室等国家级、省级创新平台,加强关键共性技术攻关,整合行业资源,实现技术与成果孵化,目前公司已获得9项国家科技进步二等奖。","listedPrice":8.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润三九,000999,华润三九股票,华润三九股票老虎,华润三九股票老虎国际,华润三九行情,华润三九股票行情,华润三九股价,华润三九股市,华润三九股票价格,华润三九股票交易,华润三九股票购买,华润三九股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润三九(000999)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润三九(000999)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}